Investment Summary

Darby Overseas Investments Invests In Acrecent Financial

On January 13, 2014, private equity firm Darby Overseas Investments invested in financial services company Acrecent Financial

Investment Highlights
  • This is Darby Overseas Investments’ 2nd transaction in the Financial Services sector.
  • This is Darby Overseas Investments’ 1st transaction in Puerto Rico.

Investment Summary
Date 2014-01-13
Target Acrecent Financial
Sector Financial Services
Investor(s) Darby Overseas Investments
Deal Type Growth Capital

Target

Acrecent Financial

Guaynabo, Puerto Rico
Acrecent Financial Corp. is a commercial finance company dedicated to providing businesses the capital needed to acquire essential equipment and information technology for which few financing alternatives exist. Acrecent tailors loan and lease facilities and offers significant structuring flexibility in a continual effort to meet customer needs.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Darby Overseas Investments

Washington, District of Columbia, United States

Investor

Category Private Equity Firm
Founded 1994
Size Large
Type Sector Agnostic
DESCRIPTION

Darby Overseas Investments is an emerging markets investment firm that sponsors and manages private equity, mezzanine finance, and fixed-income funds for institutional investors and high-net-worth individuals. Darby targets investments in Latin/South America, Asia, and Europe. Sectors of interest include consumer products, specialty retail, distribution, packaging, hotel management, energy, financial services, media and publishing. Darby was formed in 1994 and is based in Washington DC.

DEAL STATS #
Overall 29 of 35
Sector (Financial Services) 2 of 2
Type (Growth Capital) 3 of 6
Country (Puerto Rico) 1 of 1
Year (2014) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-22 Symbiotec Pharmalab

Indore, India

Symbiotec Pharmalab develops, produces and markets research-based corticosteroid and hormone APIs. Symbiotec Pharmalab was founded in 1995 and is based in Indore, India.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-10 Gramex

Búzavirág, Hungary

Gramex Drinks is a bottler of soft drinks and fruit juices for retailers and A-brand producers utilizing PET packaging. Drinks include carbonated soft drinks, fruit beverages, ready-to-drink iced-teas, lemonades, energy drinks, sports drinks, and syrups. Gramex was founded in 1998 and is based in Búzavirág, Hungary.

Buy -
Mergr

Product

Company

Legal